Immunotherapy with donor lymphocytes depleted of anti-host reactive cells results in safe and efficacious haploidentical HSCT: interim results from a phase II trial in patients with hematologic malignancies Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Roy, D
  • Maertens, J
  • Walker, I
  • Foley, Ronan
  • Lewalle, P
  • Selleslag, D
  • Velthuis, J
  • Gerez, L
  • Reitsma, K
  • Wagena, E
  • Roy, J
  • Lachance, S
  • Mielke, S

publication date

  • April 2014